GlassScriptPhysician profile
Pinkal Patel
NPI 1528016508
$1,997.13
in general payments reported to CMS, 2019-2025
11 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,384 · 2020: $88.08 · 2022: $20.40 · 2023: $51.83 · 2024: $290 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,460.70 | 2019-2020 | |
| Ovik Health, LLC | $211.97 | 2024 | Coflex Tlc |
| Dexcom, INC. | $90.00 | 2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $69.41 | 2020-2025 | Airsupra |
| Radius Health, INC. | $45.47 | 2022-2023 | Tymlos |
| Abbvie INC. | $26.76 | 2023 | |
| Glaxosmithkline, LLC. | $24.39 | 2024 | Arexvy, Shingrix |
| Eisai INC. | $22.74 | 2025 | |
| Astellas Pharma US INC | $17.79 | 2025 | Veozah |
| Lilly USA, LLC | $14.31 | 2025 | Mounjaro, Zepbound |
| Paratek Pharmaceuticals, INC. | $13.59 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pinkal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.